FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947517680> ?p ?o ?g. }

• W2947517680 endingPage "121" @default.
• W2947517680 startingPage "117" @default.
• W2947517680 abstract "Objective: To evaluate the potential protective effect of irbesartan on atherosclerotic progression using rosuvastatin as a positive control.&#x0D; Methods: Twenty local domestic rabbits were randomly divided into four groups, five rabbits per each group. The first group (I), rabbits were receiving normal diet; the second group (II), rabbits were receiving 2 % cholesterol diet; the third group (III), rabbits were receiving rosuvastatin and 2% cholesterol diet and; the fourth group (IV), rabbit were receiving irbesartan and 2% cholesterol diet. Serum level of cholesterol, triglycerides, LDL, VLDL and HDL were determined after 12 weeks of the study. Serum level of high sensitive C-reactive protein, ICAM1and VCAM1 were measured after 12 weeks of the study. Total antioxidant activity was also determined. Aortic tissue sent for histopathological examination of atherosclerosis lesion.&#x0D; Result: Data of this study have showed that atherogenic diet caused an increase in serum level of TC, LDL, VLDL and TG and a decrease in serum level of HDL. Treatment of rabbits with irbesartan caused substantial decrease in serum lipid profile compared with untreated rabbit receiving atherogenic diet. No significant difference was seen between irbesartan- and rosuvastatin-treated rabbits in all lipid parameters measured with the exception that the HDL level in rosuvastatin-treated rabbits was significantly higher than that of irbesartan-treated rabbits. Rabbit treated with irbesartan showed a significant decrease in the serum level of high sensitive C-reactive protein, ICAM1, VCAM1 and aortic total antioxidant capacity when compared with untreated group. No significant difference was seen between irbesartan- and rosuvastatin-treated rabbits in all these inflammatory parameters measured. Histopathological examination showed that irbesartan decreased atherogenic lesion significantly when compared with untreated rabbits.&#x0D; Conclusion: Irbesartan has a potential protective effect against atherosclerosis via decreasing lipid oxidation and inflammatory mediators. In terms of lipid lowering and anti-inflammatory effects, irebsartan has similar pattern of effectiveness to rosuvastatin." @default.
• W2947517680 created "2019-06-07" @default.
• W2947517680 creator A5002895493 @default.
• W2947517680 creator A5004529790 @default.
• W2947517680 creator A5026686145 @default.
• W2947517680 creator A5087609544 @default.
• W2947517680 date "2019-04-26" @default.
• W2947517680 modified "2023-10-18" @default.
• W2947517680 title "A comparative study of anti-atherosclerotic/anti-inflammatory effect of irbesartan and rosuvastatin in hypercholesterolemic male rabbits" @default.
• W2947517680 doi "https://doi.org/10.22317/jcms.v5i2.578" @default.
• W2947517680 hasPublicationYear "2019" @default.
• W2947517680 type Work @default.
• W2947517680 sameAs 2947517680 @default.
• W2947517680 citedByCount "0" @default.
• W2947517680 crossrefType "journal-article" @default.
• W2947517680 hasAuthorship W2947517680A5002895493 @default.
• W2947517680 hasAuthorship W2947517680A5004529790 @default.
• W2947517680 hasAuthorship W2947517680A5026686145 @default.
• W2947517680 hasAuthorship W2947517680A5087609544 @default.
• W2947517680 hasBestOaLocation W29475176801 @default.
• W2947517680 hasConcept C126322002 @default.
• W2947517680 hasConcept C134018914 @default.
• W2947517680 hasConcept C2777482532 @default.
• W2947517680 hasConcept C2778163477 @default.
• W2947517680 hasConcept C2778270857 @default.
• W2947517680 hasConcept C2780259554 @default.
• W2947517680 hasConcept C2780499067 @default.
• W2947517680 hasConcept C71924100 @default.
• W2947517680 hasConcept C84393581 @default.
• W2947517680 hasConceptScore W2947517680C126322002 @default.
• W2947517680 hasConceptScore W2947517680C134018914 @default.
• W2947517680 hasConceptScore W2947517680C2777482532 @default.
• W2947517680 hasConceptScore W2947517680C2778163477 @default.
• W2947517680 hasConceptScore W2947517680C2778270857 @default.
• W2947517680 hasConceptScore W2947517680C2780259554 @default.
• W2947517680 hasConceptScore W2947517680C2780499067 @default.
• W2947517680 hasConceptScore W2947517680C71924100 @default.
• W2947517680 hasConceptScore W2947517680C84393581 @default.
• W2947517680 hasIssue "2" @default.
• W2947517680 hasLocation W29475176801 @default.
• W2947517680 hasOpenAccess W2947517680 @default.
• W2947517680 hasPrimaryLocation W29475176801 @default.
• W2947517680 hasRelatedWork W1994663145 @default.
• W2947517680 hasRelatedWork W2032958076 @default.
• W2947517680 hasRelatedWork W2034068459 @default.
• W2947517680 hasRelatedWork W2035331946 @default.
• W2947517680 hasRelatedWork W2060840406 @default.
• W2947517680 hasRelatedWork W2156783035 @default.
• W2947517680 hasRelatedWork W2389163911 @default.
• W2947517680 hasRelatedWork W2899198419 @default.
• W2947517680 hasRelatedWork W4205726400 @default.
• W2947517680 hasRelatedWork W4210761970 @default.
• W2947517680 hasVolume "5" @default.
• W2947517680 isParatext "false" @default.
• W2947517680 isRetracted "false" @default.
• W2947517680 magId "2947517680" @default.
• W2947517680 workType "article" @default.